Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06WIV
|
|||
| Former ID |
DNC009520
|
|||
| Drug Name |
Biphenyl-2-ylmethyl-(S)-pyrrolidin-3-yl-amine
|
|||
| Synonyms |
CHEMBL478836; Biphenyl-2-ylmethyl-(S)-pyrrolidin-3-yl-amine; BDBM50262725
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H20N2
|
|||
| Canonical SMILES |
C1CNCC1NCC2=CC=CC=C2C3=CC=CC=C3
|
|||
| InChI |
1S/C17H20N2/c1-2-6-14(7-3-1)17-9-5-4-8-15(17)12-19-16-10-11-18-13-16/h1-9,16,18-19H,10-13H2/t16-/m0/s1
|
|||
| InChIKey |
DGKNIGATLZIOSX-INIZCTEOSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modu... Bioorg Med Chem Lett. 2008 Aug 1;18(15):4355-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.